A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
-
Autoimmune Disorder -
Juvenile Idiopathic Arthritis
For the latest version of this information please go to www.forpatients.roche.com